annual EBITDA:
$476.12M+$112.97M(+31.11%)Summary
- As of today (May 29, 2025), MEDP annual EBITDA is $476.12 million, with the most recent change of +$112.97 million (+31.11%) on December 31, 2024.
- During the last 3 years, MEDP annual EBITDA has risen by +$256.39 million (+116.68%).
- MEDP annual EBITDA is now at all-time high.
Performance
MEDP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$120.45M-$12.43M(-9.35%)Summary
- As of today (May 29, 2025), MEDP quarterly EBITDA is $120.45 million, with the most recent change of -$12.43 million (-9.35%) on March 31, 2025.
- Over the past year, MEDP quarterly EBITDA has increased by +$9.39 million (+8.46%).
- MEDP quarterly EBITDA is now -9.35% below its all-time high of $132.88 million, reached on December 31, 2024.
Performance
MEDP quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$485.51M+$9.39M(+1.97%)Summary
- As of today (May 29, 2025), MEDP TTM EBITDA is $485.51 million, with the most recent change of +$9.39 million (+1.97%) on March 31, 2025.
- Over the past year, MEDP TTM EBITDA has increased by +$103.46 million (+27.08%).
- MEDP TTM EBITDA is now at all-time high.
Performance
MEDP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MEDP EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.1% | +8.5% | +27.1% |
| 3 y3 years | +116.7% | +73.8% | +106.2% |
| 5 y5 years | +216.5% | +201.5% | +209.9% |
MEDP EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +116.7% | -9.3% | +76.9% | at high | +106.2% |
| 5 y | 5-year | at high | +216.5% | -9.3% | +246.3% | at high | +221.1% |
| alltime | all time | at high | +443.1% | -9.3% | +1094.8% | at high | +4716.1% |
MEDP EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $120.45M(-9.4%) | $485.51M(+2.0%) |
| Dec 2024 | $476.12M(+31.1%) | $132.88M(+10.9%) | $476.12M(+8.8%) |
| Sep 2024 | - | $119.79M(+6.6%) | $437.53M(+6.8%) |
| Jun 2024 | - | $112.39M(+1.2%) | $409.52M(+7.2%) |
| Mar 2024 | - | $111.06M(+17.8%) | $382.05M(+5.2%) |
| Dec 2023 | $363.15M(+20.6%) | $94.29M(+2.7%) | $363.15M(+6.1%) |
| Sep 2023 | - | $91.79M(+8.1%) | $342.16M(+0.7%) |
| Jun 2023 | - | $84.91M(-7.9%) | $339.64M(+5.2%) |
| Mar 2023 | - | $92.16M(+25.7%) | $322.82M(+7.6%) |
| Dec 2022 | $301.04M(+37.0%) | $73.30M(-17.9%) | $299.97M(+5.4%) |
| Sep 2022 | - | $89.27M(+31.1%) | $284.74M(+11.4%) |
| Jun 2022 | - | $68.09M(-1.8%) | $255.58M(+8.6%) |
| Mar 2022 | - | $69.31M(+19.4%) | $235.43M(+7.6%) |
| Dec 2021 | $219.73M(+17.8%) | $58.07M(-3.4%) | $218.81M(-1.1%) |
| Sep 2021 | - | $60.11M(+25.4%) | $221.21M(+4.1%) |
| Jun 2021 | - | $47.94M(-9.0%) | $212.47M(+6.6%) |
| Mar 2021 | - | $52.69M(-12.9%) | $199.31M(+6.8%) |
| Dec 2020 | $186.57M(+24.0%) | $60.47M(+17.7%) | $186.57M(+11.4%) |
| Sep 2020 | - | $51.36M(+47.7%) | $167.54M(+10.8%) |
| Jun 2020 | - | $34.78M(-12.9%) | $151.22M(-3.5%) |
| Mar 2020 | - | $39.95M(-3.6%) | $156.68M(+4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $150.45M(+7.6%) | $41.44M(+18.2%) | $150.45M(+1.2%) |
| Sep 2019 | - | $35.05M(-12.9%) | $148.62M(-1.4%) |
| Jun 2019 | - | $40.24M(+19.3%) | $150.71M(+4.7%) |
| Mar 2019 | - | $33.73M(-14.8%) | $143.91M(+2.9%) |
| Dec 2018 | $139.85M(+26.0%) | $39.61M(+6.7%) | $139.85M(+9.6%) |
| Sep 2018 | - | $37.13M(+11.0%) | $127.57M(+7.0%) |
| Jun 2018 | - | $33.44M(+12.7%) | $119.22M(+5.0%) |
| Mar 2018 | - | $29.67M(+8.6%) | $113.50M(+2.3%) |
| Dec 2017 | $110.98M(+11.6%) | $27.32M(-5.1%) | $110.98M(+9.5%) |
| Sep 2017 | - | $28.79M(+3.9%) | $101.34M(+2.0%) |
| Jun 2017 | - | $27.72M(+2.1%) | $99.38M(-0.9%) |
| Mar 2017 | - | $27.15M(+53.5%) | $100.23M(+0.8%) |
| Dec 2016 | $99.45M(+11.8%) | $17.69M(-34.1%) | $99.45M(+4.2%) |
| Sep 2016 | - | $26.82M(-6.1%) | $95.45M(+2.4%) |
| Jun 2016 | - | $28.57M(+8.3%) | $93.26M(+2.3%) |
| Mar 2016 | - | $26.38M(+92.7%) | $91.14M(+2.5%) |
| Dec 2015 | $88.95M(+1.5%) | $13.69M(-44.4%) | $88.95M(+18.2%) |
| Sep 2015 | - | $24.63M(-6.9%) | $75.26M(+48.6%) |
| Jun 2015 | - | $26.44M(+9.3%) | $50.63M(+109.3%) |
| Mar 2015 | - | $24.19M(+139.9%) | $24.19M(+139.9%) |
| Mar 2014 | - | $10.08M | $10.08M |
| Dec 2013 | $87.66M | - | - |
FAQ
- What is Medpace Holdings annual EBITDA?
- What is the all time high annual EBITDA for Medpace Holdings?
- What is Medpace Holdings annual EBITDA year-on-year change?
- What is Medpace Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for Medpace Holdings?
- What is Medpace Holdings quarterly EBITDA year-on-year change?
- What is Medpace Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for Medpace Holdings?
- What is Medpace Holdings TTM EBITDA year-on-year change?
What is Medpace Holdings annual EBITDA?
The current annual EBITDA of MEDP is $476.12M
What is the all time high annual EBITDA for Medpace Holdings?
Medpace Holdings all-time high annual EBITDA is $476.12M
What is Medpace Holdings annual EBITDA year-on-year change?
Over the past year, MEDP annual EBITDA has changed by +$112.97M (+31.11%)
What is Medpace Holdings quarterly EBITDA?
The current quarterly EBITDA of MEDP is $120.45M
What is the all time high quarterly EBITDA for Medpace Holdings?
Medpace Holdings all-time high quarterly EBITDA is $132.88M
What is Medpace Holdings quarterly EBITDA year-on-year change?
Over the past year, MEDP quarterly EBITDA has changed by +$9.39M (+8.46%)
What is Medpace Holdings TTM EBITDA?
The current TTM EBITDA of MEDP is $485.51M
What is the all time high TTM EBITDA for Medpace Holdings?
Medpace Holdings all-time high TTM EBITDA is $485.51M
What is Medpace Holdings TTM EBITDA year-on-year change?
Over the past year, MEDP TTM EBITDA has changed by +$103.46M (+27.08%)